#InTheNews : From our partners at WellSpan Health and the story of a participant in the Gene Health Project who learned of his FH condition.

“I didn’t want to have this genetic condition, but I do. Now I know. And I can do something about it.”

More via WGAL: bit.ly/4co0auq

#OnTheBlog : Linked clinico-genomic data is emerging as a transformative force in precision medicine development from integrating into drug discovery, clinical trials and patient care for a range of therapeutic areas. Learn more: bit.ly/3TOObyW

#InTheNews : From our partners at MUSC Health, a Q&A with Lee H. Moultrie II, a retired Air Force Veteran and prostate cancer survivor about his participation in the In Our DNA SC program and advocating for genetics research

Read more via ASHG: bit.ly/3vuDVm3

#InTheNews : Recently-announced SVP of Life Sciences, Hylton Kalvaria spoke with Pharma's Almanac to discuss the importance of genetic data to get drugs into the patients that need them faster.

Read more of Hylton's thoughts here: bit.ly/3IEBDDP

#InTheNews : CEO James Lu spoke w/FOX8 WGHP about our partnership with @conehealth to launch population genomics in their community.

“You’re going to see the transition of genomics into standard of care, and sooner than you think,' Dr. Lu said.

Read more: bit.ly/3vdLe1c

#InTheNews : Helix's Alexandre Bolze & Renown Health's Healthy Nevada Project (@UNRmed) reveal research suggesting a combined single- and multi-gene approach to breast cancer screenings could help produce more accurate results.

Read: bit.ly/3IKQIDH

#InTheNews : The backdrop to Anna's narrative is the evolving landscape of genetic screening and awareness. In Our DNA SC is pioneering genetic screening at MUSC Health, highlighting a recognition of the role of genetics in health and disease prevention. bit.ly/3wRw1mU

#InTheNews : GenomeWeb has news of GenoMe, the project developed through a 2022 collaboration between Memorial Hermann and us offering no-cost DNA testing to the Houston community, representing the largest population genomics program in the state of Texas.
bit.ly/3V61Z9a

We are pleased to announce two AVA Digital Gold awards from the Association of Marketing and Communication Professionals (AMCP) for “Design and Engineering of the Helix Brand Website” in both technical build and creativity. Check it out here: bit.ly/3T8GJx7 #popgenomics

Join us in officially welcoming Hylton Kalvaria as SVP of Life Sciences. CEO James Lu said: “Strengthening our team with Hylton further positions Helix to ensure the power of genomics is used to improve healthcare outcomes on the largest possible scale.” bwnews.pr/3IxHsCM

The more you know about your health, the more you can do to protect it. That’s what the genoME® community health research program, our collab w/Memorial Hermann is all about.

You can read more about the launch here: bit.ly/432vM4s

A recording of our recent webinar with AMGA “Personalized Medicine & Genomics: What Your Medical Group Needs to Know” is now available. Learn how to make precision medicine a reality at your health system. Watch the recording now: bit.ly/49y3JvP

#OnTheBlog : A new Real-World Evidence study with our partners (HealthPartners, & Renown Health) shows that a majority of COVID-19 related hospitalizations could potentially be prevented with oral anti-viral treatment (like Paxlovid) in early infection. bit.ly/42DUkkb

Last chance to register for our webinar, Personalized Medicine & Genomics: What Your Medical Group Needs to Know.

Learn from leaders Aldo Carmona & Cassie Hajek how genomics can advance personalized medicine & boost provider-patient impact.

Register Now bit.ly/3vLmVaO

There is still time to register for our upcoming webinar, Personalized Medicine & Genomics: What Your Medical Group Needs to Know.

Learn from experts how genomics can enhance personalized medicine and boost provider-patient impact.

Register Now bit.ly/497CKa7

#InTheNews : Precision Medicine Online wrote a deep-dive analysis of the findings of the Healthy Nevada Project and Helix's study involving 25,000 women informing when patients might be able to safely delay mammograms based on their genetic profiles.
bit.ly/3SsdrKJ

#InTheNews : @USNews spoke w/head of infectious diseases, shishi luo, about the winter COVID-19 wave, saying Helix’s data shows the benefits of COVID-19 vaccines among older populations and future vaccine campaigns might be more targeted to that age group.
bit.ly/493UlA3

The future of genomics and personalized medicine is rapidly evolving. Join us for our upcoming webinar with Aldo Carmona and Catherine Hajek to learn what your medical group needs to know to scale the use of genomics to deliver improved patient care.

bit.ly/48XzApo

#InTheNews : On a recent study looking at prescribing gaps among high-risk adults for Covid, co-author Matt Levy, Ph.D. hypothesized: antiviral “treatment may not be prioritized due to overall lower numbers of hospitalizations and deaths.” (via Forbes) bit.ly/3RWxNtV

#OnTheBlog : We summarize our newest JAMA Oncology publication that demonstrates how genetic testing could actually help identify women that may be at LOWER risk for breast cancer, and could potentially defer their mammogram screenings by 5-10 years. bit.ly/3voC81u